Reconstitution is one of those subjects where the details matter more than the headlines. This page pulls together the background, the mechanisms, and the practical points readers ask about most.
Updated 2025-08-07. Numbers and descriptions here follow the published literature rather than marketing material.
Two related peptides circulate under the CJC-1295 label, and they differ mainly in how long they persist in circulation. The version carrying a drug affinity complex includes a maleimidopropionic acid linker that forms a covalent bond with serum albumin. The other version, usually written as modified GRF(1-29) or tetrasubstituted GRF(1-29), lacks that linker and is cleared quickly. Mixing the two produces inconsistent readings of published half-life values, because the linker rather than the receptor-facing sequence drives most of the difference.
The core sequence keeps the receptor-binding region of GHRH while replacing four positions that are vulnerable to dipeptidyl peptidase-4 and other proteases. Substitutions at positions 2, 8, 15, and 27 raise metabolic stability relative to the natural hormone. The N-terminal residues remain essential for activity, so changes there generally lower potency. Molecular weight sits near 3368 daltons for the tetrasubstituted analog without the linker, while the albumin-binding form is heavier because of the added maleimide group.
Naming in this area is inconsistent, and readers should treat product labels with care. In much of the literature and in vendor catalogs, the unqualified term refers to the albumin-binding version, while the version lacking the DAC group appears as modified GRF(1-29), mod GRF(1-29), or the same name with a without-DAC qualifier. Because one abbreviation has been applied to both materials, the only reliable way to identify a sample is to check the stated sequence and the presence of the linker.
CJC-1295 is the name used for a synthetic peptide modeled on growth hormone-releasing hormone, the hypothalamic signal that prompts the pituitary to release growth hormone. The compound was described by a Canadian drug discovery company in the mid-2000s as a long-acting research tool. Two closely related molecules share the name in practice: one carries a drug affinity complex, or DAC, group, and one does not. The distinction matters because the two behave differently in circulation.
The peptide backbone corresponds to GRF(1-29), the first 29 residues of native growth hormone-releasing hormone, which retains most of the receptor-activating activity of the full-length molecule. Four substitutions distinguish the analog from the natural sequence: D-alanine at position 2, glutamine at position 8, alanine at position 15, and leucine at position 27. These changes slow cleavage by dipeptidyl peptidase IV, the enzyme that degrades native hormone in plasma within minutes. The outcome is improved enzymatic stability combined with a still brief residence time when no additional modification is present.
| Property | Value | Notes |
|---|---|---|
| Class | Synthetic peptide | GHRH receptor agonist |
| Sequence length | 29 amino acids | Derived from human GHRH |
| Molecular weight | About 3368 Da without linker | Albumin-binding form is heavier |
| Appearance | White to off-white lyophilized powder | Common form for research reference material |
| Typical storage | -20 °C or below, desiccated | Protect powder from light and moisture |
Pharmacokinetic behaviour differs sharply between the two forms. The DAC-bearing peptide shows an extended circulation time measured in days, whereas the version without the complex is cleared within roughly half an hour. This gap shapes how researchers design dosing schedules in animal models. Whether the prolonged presence of the DAC form produces effects meaningfully different from the short-acting variant remains an open question, since comparative human data are scarce.
CJC-1295 is a synthetic peptide designed to mimic growth hormone-releasing hormone (GHRH), the endogenous signal that prompts the pituitary gland to release growth hormone. The compound is a modified fragment of the natural hormone, spanning the first twenty-nine amino acids of GHRH with several substitutions that slow enzymatic breakdown. Two variants circulate in research settings: one carrying a drug affinity complex (DAC) and one without it. The DAC-free form is frequently labelled Mod GRF(1-29) in catalogs and discussion forums.
Peptide degradation proceeds mainly through hydrolysis, oxidation of methionine, and deamidation of asparagine or glutamine residues. The maleimide group on the albumin-binding variant can also react with thiols or hydrolyze in aqueous media. Because these pathways accelerate with temperature and pH extremes, handling conditions strongly influence measured stability. Stability data in the public literature are limited and often generated under differing conditions, so general statements about shelf life should be read as approximate.
Research material is normally supplied as a freeze-dried powder in sealed vials. In that state the peptide is comparatively robust, but prolonged exposure to warmth, moisture, or light accelerates degradation. Storage at minus twenty degrees Celsius or lower, with desiccant and protection from light, is the commonly described practice. Vials should be allowed to reach room temperature before opening to limit condensation on the powder. Moisture uptake during handling is a recognized source of variability in later measurements.
Reconstitution is typically performed with sterile water or bacteriostatic water, added slowly against the vial wall. The resulting solution should be clear and colorless; cloudiness or visible particles suggest a problem with the material or the diluent. Once in solution, the peptide is less stable than the dry powder. Refrigerated storage at two to eight degrees Celsius is common for short-term holding, while freezing aliquots is described for longer periods.
=== English === Order, Sons of St. George - Organized after the Civil War by Englishmen in the anthracite coal-mining region of Pennsylvania to counter the Molly Maguires. The organization "took permanent shape" at Scranton in 1871. Membership was open to "Englishmen, their sons, and grandsons, wherever born". Beneficiary membership was limited to those between 18 and 50; those over 50 were allowed honorary membership. The Order required belief in a Supreme Being, reverence for the Holy Bible, and loyalty to one's adopted country. By 1896 the order had about 35,000 members in the United States, Canada, and Hawaii. Ritual based on the legend of St. George included a "language of words, signs and grips" that the member learned upon initiation which could identify him to other members of the order. The Orders emblem was St. George conquering the dragon. The system of sick benefits varied by the lodge and the inclination of members. There was also a funeral benefit for members and their wives and a benevolent fund for brethren and "any worthy Englishman in distress". Some lodges also provided physicians and medicine for sick members. There was also a female auxiliary, the Daughters of St. George, but it was not officially recognized by the Supreme Lodge. In 1923 the Order was accused of promoting pro-British propaganda in textbooks used in New York by a representative of Mayor John Francis Hylan. Sons of England Benevolent Society - Fraternal order for Canadians of English descent.
==== United Kingdom ==== In the United Kingdom, the three medical Royal Colleges (the Royal College of Physicians of London, the Royal College of Physicians of Edinburgh and the Royal College of Physicians and Surgeons of Glasgow) are responsible for setting curricula and training programmes through the Joint Royal Colleges Postgraduate Training Board (JRCPTB), although the process is monitored and accredited by the independent General Medical Council (which also maintains the specialist register). Doctors who have completed medical school spend two years in foundation training completing a basic postgraduate curriculum. After two years of Core Medical Training (CT1/CT2), or three years of Internal Medicine Training (IMT1/IMT2/IMT3) as of 2019, since and attaining the Membership of the Royal College of Physicians, physicians commit to one of the medical specialties:
In the 1950s, Har Gobind Khorana and co-workers developed a phosphodiester method where 3'-O-acetylnucleoside-5'-O-phosphate 2 (Scheme 3) was activated with N,N'-dicyclohexylcarbodiimide (DCC) or 4-toluenesulfonyl chloride (Ts-Cl). The activated species were reacted with a 5'-O-protected nucleoside 1 to give a protected dinucleoside monophosphate 3. Upon the removal of 3'-O-acetyl group using base-catalyzed hydrolysis, further chain elongation was carried out. Following this methodology, sets of tri- and tetradeoxyribonucleotides were synthesized and were enzymatically converted to longer oligonucleotides, which allowed elucidation of the genetic code. The major limitation of the phosphodiester method consisted in the formation of pyrophosphate oligomers and oligonucleotides branched at the internucleosidic phosphate. The method seems to be a step back from the more selective chemistry described earlier; however, at that time, most phosphate-protecting groups available now had not yet been introduced. The lack of the convenient protection strategy necessitated taking a retreat to a slower and less selective chemistry to achieve the ultimate goal of the study.
In March 1997, the company patented this combination. The drug was approved in June 1997, by the FDA as Imodium Multi-Symptom Relief in the form of a chewable tablet. A caplet formulation was approved in November 2000. In November 1993, loperamide was launched as an orally disintegrating tablet based on Zydis technology. In 2013, loperamide was added to the WHO Model List of Essential Medicines.
In the early 2020s, Brazil became one of the hardest hit countries during the COVID-19 pandemic, receiving the second-highest death toll worldwide after the United States. In May 2021, Luiz Inácio Lula da Silva stated that he would run for a third term in the 2022 Brazilian general election against Bolsonaro. In October 2022, Lula was in first place in the first round, with 48.43% of the support from the electorate, and received 50.90% of the votes in the second round. On 8 January 2023, a week after Lula's inauguration, a mob of Bolsonaro's supporters attacked Brazil's federal government buildings in the capital, Brasília, after several weeks of unrest.
Sources: en.wikipedia.org
=== Health === In 1996, Morgan was diagnosed with diabetes mellitus and for years has been an alcoholic. Morgan has conceded that many of his own troubles were incorporated within 30 Rock episodes. In early December 2010, Morgan received a kidney transplant necessitated by his diabetes and alcohol use. In August 2023, Morgan responded to a comment about his healthy appearance during an episode of Today with Hoda & Jenna by disclosing that he was using semaglutide. In March 2024, he told Jimmy Fallon that he had "learned to out-eat Ozempic" and "gained 40 lbs," but later clarified that he was joking, saying "Ozempic did great by me and I was glad to use it." On March 17, 2025, while sitting courtside at an NBA basketball game at Madison Square Garden between the New York Knicks and Miami Heat, Morgan experienced an episode of food poisoning, which caused him to vomit onto the basketball court sideline and suffer a bloody nose. He joked on his Instagram post from the hospital saying, "More importantly, the Knicks are now 1-0 when I throw up on the court so maybe I'll have to break it out again in the playoffs."
The white flour produced after milling of wheat has only 67% of its original riboflavin amount left, so white flour is enriched in some countries. Riboflavin is also added to ready-to-eat breakfast cereals. It is difficult to incorporate riboflavin into liquid products because it has poor solubility in water, hence the requirement for riboflavin-5'-phosphate (FMN, also called E101 when used as colorant), a more soluble form of riboflavin. The enrichment of bread and ready-to-eat breakfast cereals contributes significantly to the dietary supply of the vitamin. Free riboflavin is naturally present in animal-sourced foods along with protein-bound FMN and FAD. Cows' milk contains mainly free riboflavin, but both FMN and FAD are present at low concentrations.
They cited concerns over deviations from standard acquisition processes and a dome subscription model that could "give Musk undue influence over national security." Another key conflict of interest involves four-star general Terrence J. O'Shaughnessy, former head of U.S. homeland missile defense, who now reports directly to Musk at SpaceX. Michael D. Griffin, founder of the Space Development Agency behind the Golden Dome, has also faced scrutiny. After traveling to Russia with a young Musk in 2001 to study ICBMs, Griffin steered $2 billion in NASA contracts to Musk's newfound space company. SpaceX has since secured missile-tracking satellite contracts through Griffin's SDA as part of its Starshield program. Griffin also serves as an advisor to Castelion, a startup founded by former SpaceX executives that seeks to mass-produce hypersonic weapons. General Michael A. Guetlein of the U.S. Space Force, was nominated to run the program in June 2025, was confirmed by the Senate the following month, and assumed the position on July 21, 2025. Dr. Douglas Matty was named to head the project in January 2026. Republicans included $25 billion for the Golden Dome in their 2025 reconciliation spending bill. The fiscal 2026 defense appropriations bill, passed by Congress on February 3, 2026, included $13.4 billion for space and missile defense systems for the Golden Dome. As of December 2025, the U.S.
A D-peptide is a short sequence of D-amino acids connected by peptide bonds. Since ribosomes are specific to L-amino acids, the vast majority of naturally occurring peptides and proteins are composed of L-amino acids. One exception are the D-peptides in the peptidoglycan of bacterial cell walls. D-peptides rarely occur naturally in organisms and are not easily digested or degraded. D-peptide peptidomimetics are D-peptides designed to mimic natural L-peptides that commonly have therapeutic properties. A peptide with secondary structure cannot be mimicked by its retro-inverse, as linking in the reverse order breaks many backbone interactions essential for the secondary structure. An approach to mimicking these peptides is by searching for similar (sidechain) structures in a mirrored copy of the Protein Data Bank for the structured elements, and then linking the sections by retro-inversed versions of the loops found in the original protein.
=== Opioid overdose === Naloxone is used for the emergency treatment of an overdose. It can be given by many routes (e.g., intramuscular (IM), intravenous (IV), subcutaneous, intranasal, and inhalation) and acts quickly by displacing opioids from opioid receptors and preventing the activation of these receptors. Naloxone kits are recommended for laypersons who may witness an opioid overdose, for people with large prescriptions for opioids, those in substance use treatment programs, and those recently released from incarceration. Since naloxone is a life-saving medication, many areas of the U.S. have implemented standing orders for law enforcement to carry and give it as needed. In addition, naloxone can be used to challenge a person's opioid abstinence status before starting a medication such as naltrexone, which is used in the management of opioid addiction. Good Samaritan laws typically protect bystanders who administer naloxone. In the U.S., at least 40 states have Good Samaritan laws to encourage bystanders to take action without fear of prosecution. As of 2019, 48 states give pharmacists the authority to distribute naloxone without an individual prescription. Homicide, suicide, accidents and liver disease are also opioid-related causes of death for those with OUD. Many of these causes of death are unnoticed due to the often limited information on death certificates.
Sources: en.wikipedia.org
Natural GHRH is degraded quickly by dipeptidyl peptidase-4 and related enzymes, giving it a half-life measured in minutes. CJC-1295 carries substitutions that slow that breakdown, so it stays intact longer. Both act at the same pituitary receptor and produce the same class of signal.
The label was first attached to the albumin-binding form during early development work. A shorter analog without the linker later became known by the same name in informal use. Published papers normally state which version was studied, so the methods section resolves the ambiguity.
It is a synthetic peptide rather than a steroid, and it does not occur naturally in the body. Its sequence is derived from a hypothalamic hormone called growth hormone-releasing hormone. It works as a receptor agonist rather than as a replacement for that hormone.
No. It is a laboratory-made analog of growth hormone-releasing hormone. The natural hormone is a 44-residue peptide, while the analog is built on a shorter 29-residue fragment.